I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 22% ± 3% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 20% ± 4% | |
| classical monocyte | 4 studies | 21% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 22% ± 4% | |
| conventional dendritic cell | 4 studies | 18% ± 3% | |
| epithelial cell | 4 studies | 34% ± 18% | |
| T cell | 3 studies | 33% ± 15% | |
| leukocyte | 3 studies | 20% ± 2% | |
| non-classical monocyte | 3 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 3% | |
| mucosal invariant T cell | 3 studies | 22% ± 4% | |
| fibroblast | 3 studies | 18% ± 2% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| innate lymphoid cell | 3 studies | 21% ± 1% | |
| glutamatergic neuron | 3 studies | 25% ± 7% | |
| gamma-delta T cell | 3 studies | 25% ± 7% | |
| regulatory T cell | 3 studies | 17% ± 1% |
